(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — GSK on Monday said that ...

Diageo (DEO) has considered a multitude of internal and external candidates, including Emma Walmsley, outgoing CEO of GSK (GSK), for the company’s leadership role, The Financial Times reported on ...

Dame Emma Walmsley, CEO of GSK arrives for a business roundtable attended by President Donald Trump and Britain's Prime Minister Keir Starmer at Chequers near ...

GSK CEO Emma Walmsley will be stepping aside after nine years. Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief ...